Predictive impact of ARID1A status in solid tumors

被引：0
|
作者：
Ampanattu, S. Daniel [1 ]
Ahmed, G. [1 ]
Thapa, B. [1 ]
Janardan, A. [2 ]
Vallejos, A. [3 ]
Taylor, B. [3 ]
Huaying, D. [4 ]
Szabo, A. [4 ]
George, B. [1 ]
机构：
[1] Med Coll Wisconsin, Hematol & Oncol, Milwaukee, WI USA
[2] Med Coll Wisconsin, Med, Milwaukee, WI USA
[3] Med Coll Wisconsin, Biomed Informat, Milwaukee, WI USA
[4] Med Coll Wisconsin, Biostat, Milwaukee, WI USA
来源：
EUROPEAN JOURNAL OF CANCER | 2022年 / 174卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
265
引用
收藏
页码：S96 / S96
页数：1
相关论文
共 50 条
  • [1] The predictive values of ARID1A mutations for response to immune checkpoint inhibitors are varied in different types of solid tumors.
    Zhou, Chengzhi
    Niu, Yanling
    Ma, Tonghui
    Yuan, Hongling
    CANCER RESEARCH, 2021, 81 (13)
  • [2] Endometrial Carcinomas: Exploring the Concordance Between ARID1A Immunohistochemistry and ARID1A Mutational Status
    Storozuk, Tanner
    Wang, Peng
    Lastra, Ricardo
    Bennett, Jennifer
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 748 - 749
  • [3] Optimised ARID1A immunohistochemistry is an accurate predictor of ARID1A mutational status in gynaecological cancers
    Khalique, Saira
    Naidoo, Kalnisha
    Attygalle, Ayoma D.
    Kriplani, Divya
    Daley, Frances
    Lowe, Anne
    Campbell, James
    Jones, Thomas
    Hubank, Michael
    Fenwick, Kerry
    Matthews, Nicholas
    Rust, Alistair G.
    Lord, Christopher J.
    Banerjee, Susana
    Natrajan, Rachael
    JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2018, 4 (03): : 154 - 166
  • [4] Endometrial Carcinomas: Exploring the Concordance Between ARID1A Immunohistochemistry and ARID1A Mutational Status
    Storozuk, Tanner
    Wang, Peng
    Lastra, Ricardo
    Bennett, Jennifer
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 748 - 749
  • [5] Mutations and deletions of ARID1A in breast tumors
    S Cornen
    J Adelaide
    F Bertucci
    P Finetti
    A Guille
    D J Birnbaum
    D Birnbaum
    M Chaffanet
    Oncogene, 2012, 31 : 4255 - 4256
  • [6] Mutations and deletions of ARID1A in breast tumors
    Cornen, S.
    Adelaide, J.
    Bertucci, F.
    Finetti, P.
    Guille, A.
    Birnbaum, D. J.
    Birnbaum, D.
    Chaffanet, M.
    ONCOGENE, 2012, 31 (38) : 4255 - 4256
  • [7] The clinicopathologic significance of the ARID1A expression in ovarian epithelial tumors
    Ayaz, D.
    Diniz, G.
    Sayhan, S.
    Kaya, O.
    Kahraman, D. S.
    Karadeniz, T.
    Sanci, M.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2019, 40 (04) : 567 - 571
  • [8] The Role of ARID1A in Tumors: Tumor Initiation or Tumor Suppression?
    Xu, Shouying
    Tang, Chao
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [9] Genomic and proteomic characterization of ARID1A chromatin remodeller in ampullary tumors
    Nastase, Anca
    Teo, Jin Yao
    Heng, Hong Lee
    Ng, Cedric Chuan Young
    Myint, Swe Swe
    Rajasegaran, Vikneswari
    Loh, Jia Liang
    Lee, Ser Yee
    Ooi, London Lucien
    Chung, Alexander Yaw Fui
    Chow, Pierce Kah Hoe
    Cheow, Peng Chung
    Wan, Wei Keat
    Azhar, Rafy
    Khoo, Avery
    Xiu, Sam Xin
    Alkaff, Syed Muhammad Fahmy
    Cutcutache, Ioana
    Lim, Jing Quan
    Ong, Choon Kiat
    Herlea, Vlad
    Dima, Simona
    Duda, Dan G.
    Teh, Bin Tean
    Popescu, Irinel
    Lim, Tony Kiat Hon
    AMERICAN JOURNAL OF CANCER RESEARCH, 2017, 7 (03): : 484 - 502
  • [10] The impact of ARID1A mutation on molecular characteristics in colorectal cancer
    Tokunaga, Ryuma
    Xiu, Joanne
    Goldberg, Richard M.
    Philip, Philip A.
    Seeber, Andreas
    Battaglin, Francesca
    Arai, Hiroyuki
    Lo, Jae Ho
    Naseem, Madiha
    Puccini, Alberto
    Berger, Martin D.
    Soni, Shivani
    Zhang, Wu
    Chen, Sting
    Hwang, Jimmy J.
    Shields, Anthony F.
    Marshall, John L.
    Baba, Hideo
    Korn, W. Michael
    Lenz, Heinz-Josef
    EUROPEAN JOURNAL OF CANCER, 2020, 140 : 119 - 129
12345